Organ and kidney function preservation in renal cell carcinoma

被引:0
|
作者
Schenck, M. [1 ]
Eder, R. [1 ]
Ruebben, H. [1 ]
Niedworok, C. [1 ]
Tschirdewahn, S. [1 ]
机构
[1] Urol Univ Klin Essen, D-45122 Essen, Germany
来源
UROLOGE | 2014年 / 53卷 / 09期
关键词
Renal cell carcinoma; Organ-preserving renal tumour surgery; Partial nephrectomy; Survival; Therapy success; NEPHRON-SPARING SURGERY; CANCER-SPECIFIC SURVIVAL; QUALITY-OF-LIFE; RADICAL NEPHRECTOMY; RADIOFREQUENCY ABLATION; PROGNOSTIC NOMOGRAM; NATURAL-HISTORY; COMPLICATIONS; TUMORS; STRATIFICATION;
D O I
10.1007/s00120-014-3558-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The organ-preserving partial nephrectomy has increasingly established itself in small unilateral renal tumours (< 4 cm) with contralateral healthy kidney and counter gained in recent years in importance. There was found a significantly increased cardiovascular mortality rate and deteriorated quality of life, the more intact kidney tissue has been removed. In the present study, the influence of pre- and perioperative factors on direct postoperative course was examined, including 5-year survival rate and relapse behaviour after open organ-preserving partial nephrectomy in our own collective. In this retrospective study of 1657 patients were collected, who underwent surgery between 2007 and 2013 in the Department of Urology at the University Hospital Essen because of a renal tumour. 38 % of these operations (n = 636) were performed organ-preserving. In this trial there are factors identified that have an impact on need of blood transfusion and length of hospitalization in organ-preserving operation method. No independent parameter can be determined for the need of blood transfusion. Tumour size and thus time of resection procedure does not affect the need of erythrocytes administration. In addition, the tumour size influences neither the postoperative serum-haemoglobin nor serum-creatinine. Increased patient age and female gender are identified as non-modifiable factors, which cause a longer hospitalisation. Postoperative pain therapy can be considered as a variable size, which does not affect the length of hospital stay. Modifiable factors that increase the overall length of stay, however, are the type of direct postoperative monitoring (ICU vs. anaesthetic recovery room) and the administration of blood transfusions. There are constant factors, which can be associated with a longer residence time in the framework of an organ-preserving partial nephrectomy. Further there is shown evidence of the independence of the tumour size - in addition to proven good oncological results - of an extension of indication of organ-preserving nephrectomy of tumours > 4 cm.
引用
收藏
页码:1329 / 1343
页数:15
相关论文
共 50 条
  • [21] Comparison of Renal Function after Partial Nephrectomy and Radical Nephrectomy for Renal Cell Carcinoma
    Miyamoto, Katsutoshi
    Inoue, Shogo
    Kajiwara, Mitsuru
    Teishima, Jun
    Matsubara, Akio
    UROLOGIA INTERNATIONALIS, 2012, 89 (02) : 227 - 232
  • [22] Chronic Kidney Disease in Patients With Renal Cell Carcinoma
    Chang, Anthony
    Finelli, Antonio
    Berns, Jeffrey S.
    Rosner, Mitchell
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2014, 21 (01) : 91 - 95
  • [23] Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review
    Dahle, Dag Olav
    Skauby, Morten
    Langberg, Carl Wilhelm
    Brabrand, Knut
    Wessel, Nicolai
    Midtvedt, Karsten
    TRANSPLANTATION, 2022, 106 (01) : E52 - E63
  • [24] Predicting Occult Multifocality of Renal Cell Carcinoma
    Tsivian, Matvey
    Moreira, Daniel M.
    Caso, Jorge R.
    Mouraviev, Vladimir
    Madden, John F.
    Bratslavsky, Gennady
    Robertson, Cary N.
    Albala, David M.
    Polascik, Thomas J.
    EUROPEAN UROLOGY, 2010, 58 (01) : 118 - 126
  • [25] Is organ-sparing surgical treatment the standard for renal cell carcinoma?
    Roos, F. C.
    Brenner, W.
    Thueroff, J. W.
    Hampel, C.
    ONKOLOGE, 2010, 16 (02): : 140 - +
  • [26] Incidental Discovery of a Renal Cell Carcinoma on Native Kidney Biopsy
    Sperati, C. John
    Alachkar, Nada
    Rodriguez, Ronald
    Haas, Mark
    Choi, Michael J.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (01) : 175 - 180
  • [27] Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney
    Tan, Vivian S.
    Correa, Rohann J. M.
    Warner, Andrew
    Ali, Muhammad
    Muacevic, Alexander
    Ponsky, Lee
    Ellis, Rodney J.
    Lo, Simon S.
    Onishi, Hiroshi
    Swaminath, Anand
    Kwon, Young Suk
    Morgan, Scott C.
    Cury, Fabio L.
    Teh, Bin S.
    Mahadevan, Anand
    Kaplan, Irving D.
    Chu, William
    Hannan, Raquibul
    Staehler, Michael
    Zaorsky, Nicholas G.
    V. Louie, Alexander
    Siva, Shankar
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (06): : 1527 - 1534
  • [28] Recent Advances in the Management of Localized and Locally Advanced Renal Cell Carcinoma: A Narrative Review
    Dhanji, Sohail
    Wang, Luke
    Liu, Franklin
    Meagher, Margaret F.
    Saidian, Ava
    Derweesh, Ithaar H.
    RESEARCH AND REPORTS IN UROLOGY, 2023, 15 : 99 - 108
  • [29] Radiofrequency ablation of synchronous bilateral renal cell carcinoma
    Zhang, Shiwei
    Zhao, Xiaozhi
    Ji, Changwei
    Liu, Guangxiang
    Li, Xiaogong
    Zhang, Gutian
    Gan, Weidong
    Guo, Hongqian
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (03) : 241 - 247
  • [30] Imaging in the Follow-Up of Renal Cell Carcinoma
    Patel, Uday
    Sokhi, Heminder
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 198 (06) : 1266 - 1276